Implantable medical device with a nonhermetic battery

ABSTRACT

An implantable medical device (IMD) including a nonhermetic battery is described. The IMD includes components and a power source module that includes the nonhermetic battery. The IMD also includes a barrier to substantially impede movement of substances from the nonhermetic battery to the components. The barrier may include a hermetic feedthrough, a gel, a polymer, or a solid electrolyte within the nonhermetic battery, and a seal member. The barrier may also be a material that encapsulates the nonhermetic battery and a getter within the IMD. In some embodiments, the IMD comprises a modular IMD including an interconnect member. In that case, the barrier may include a material that fills at least a portion of a void defined by the interconnect member. A length and a cross-sectional area of the interconnect member may also act as a barrier.

This application claims the benefit of U.S. provisional application Ser.No. 60/471,262, filed May 16, 2003, the entire content of which isincorporated herein by reference.

TECHNICAL FIELD

The invention relates to medical devices, and more particularly, toimplantable medical devices.

BACKGROUND

Depending on the application for which they are implanted in a patient,implantable medical devices (IMDs) may include a variety of electricaland/or mechanical components. Typically, an IMD includes a rigid housingthat houses all of its components, which are generally fragile, toprotect the components from forces to which they would otherwise beexposed when implanted within the human body. In order to avoidpotentially harmful interactions between the components and bodilyfluids, e.g., corrosion, IMD housings are typically hermetically sealed.Many IMD housings are fabricated from titanium because of its desirablerigidity and biocompatibility.

The size and shape of an IMD housing is dependent on the sizes andshapes of the components of the IMD. Large components common to mostIMDs include a battery and a circuit board that carries digitalcircuits, e.g., integrated circuit chips and/or a microprocessor, andanalog circuit components. Attempts have been made to reduce the size ofthe IMD housing by reducing the size of these components, changing theshape of these components, and organizing these components within theIMD housing to avoid empty space within the housing.

However, the functional and safety requirements of IMDs have limitedattempts to reduce the size and improve the shape of rigid IMD housings.For example, many types of batteries useful for powering an IMD can emitsubstances that would be harmful to the patient in which the IMD isimplanted and to the other components of the IMD. Consequently, existingIMDs typically use hermetic batteries, e.g., batteries within ahermetically sealed housing or case, as a source of power. However, theneed to make the housing or case of the battery hermetic limits thethinness and shapes that the battery may have, e.g., due to need forhermetic feedthroughs and the type of welding required for a hermetichousing or case. These limits to the size and shape that a hermeticbattery may have in turn limit the ability of IMD designers to reducethe size and shape of IMD housings.

Consequently, the size, shape and rigidity of IMD housings still greatlylimit the locations within the human body where an IMD can bepractically implanted. Due to these limitations, an IMD is typicallyimplanted within the abdomen, upper pectoral region, or subclavicularregion of a patient. Leads or catheters must be used in order to delivertherapy or monitor a physiological parameter at a location of the bodyother than where the IMD is implanted. Implantation and positioning ofleads and catheters can be difficult and time-consuming from theperspective of a surgeon, particularly where the IMD is located asignificant distance from the treatment or monitoring site. Moreover,the increased surgical time, increased surgical trauma, and increasedamount of implanted material associated with the use of leads andcatheters can increase the risk to the patient of complicationsassociated with the implantation of an IMD.

For example, IMDs that are used to treat or monitor the brain, e.g., todeliver deep brain stimulation (DBS) therapy, are implanted somedistance away from the brain, e.g., within the subclavicular region ofpatients. The long leads that connect the implantable medical device toelectrodes implanted within the brain require tunneling under the scalpand the skin of the neck, thereby requiring extensive surgery and aprolonged amount of time under general anesthesia during the implantprocedure, as well as increased recovery time. In some cases, tunnelingthe leads under the scalp and skin of the neck requires an additionalsurgical procedure under general anesthesia. The lengthy tract along theleads is more susceptible to infection, and the leads can erode theoverlying scalp, forcing removal so that the scalp can heal. Further,the long leads running under the scalp and through the neck are moresusceptible to fracture due to torsional and other forces caused bynormal head and neck movements.

SUMMARY

In general, the invention is directed to an implantable medical device(IMD) including a nonhernetic battery, i.e., a battery that is containedwithin a nonhermetic housing or other nonhermetic enclosure. The IMDincludes components and a power source module that includes thenonhermetic battery. The nonhermetic battery delivers power to thecomponents via an electrical conductor that extends from the nonhermeticbattery to the components. In some embodiments the IMD may comprise amodular IMD. In those embodiments, the IMD includes a control modulethat includes the components within a control module housing and aninterconnect member through which the electrical conductor extends tocouple the control module and the power source module. In some cases,the components may comprise control electronics that control thefunctioning of the IMD.

Conventionally, nonhermetic batteries are not used in IMDs due to thepotential hazard to the components within the IMD. The nonhermeticbattery may leak substances that contain corrosive compounds, such asvaporized organic solvents, gasses produced during operation of thebattery, and liquid electrolytes including salts. The substances maymove from the nonhermetic battery to the components within the IMD wherethe corrosive compounds could cause damage. The damage would not only beharmful to the IMD, but could potentially be harmful to a patient inwhom the IMD is implanted. For example, the substances from thenonhermetic battery that contain corrosive compounds may enter thepatient's body. In addition, the damaged IMD may malfunction, e.g., andabruptly quit delivering therapy or deliver an inappropriate therapy tothe patient.

An embodiment of the invention described herein includes a barrierwithin the IMD to substantially impede movement of substances from thenonhermetic battery to the components. The barrier may include, forexample, a hermetic feedthrough through which the electrical conductorextends, a gel, a polymer, or a solid electrolyte within the nonhermeticbattery, and a seal member. The barrier may also be a material thatencapsulates the nonhermetic battery and a getter within a housing ofthe power source module. In general, a getter is a material which, whenused in a closed container, absorbs or reacts with the substance in thecontainer to neutralize the substance. A getter may be a getter for onesubstance and may not have any effect upon another substance.

In embodiments including the control module and the interconnect member,the barrier may include a material that fills at least a portion of avoid defined by the interconnect member and a getter within theinterconnect member or the control module housing. The length and/or thecross-sectional area of the interconnect member may also act as abarrier; in some embodiments the interconnect member is crimped tocreate a reduced-cross-sectional area region that serves to restrict themovement of substances. The IMD may include one of the barriers listedabove or any combination of the barriers to impede the movement ofsubstances from the nonhermetic battery.

In one embodiment, the invention is directed to an implantable medicaldevice comprising components and a power source module. The power sourcemodule includes a nonhermetic battery. An electrical conductor deliverspower from the nonhermetic battery to the components. A barrier thatsubstantially impedes movement of substances from the nonhermeticbattery to the components is located between the components and thenonhermetic battery.

In another embodiment, the invention is directed to an implantablemedical device comprising components and a power source module. Thepower source module includes a power source module housing and anonhermetic battery within the power source module housing. Anelectrical conductor delivers power from the nonhermetic battery to thecomponents. A material that substantially impedes movement of substancesfrom the nonhermetic battery to the components is included within thepower source module housing.

In another embodiment, the invention is directed to an implantablemedical device comprising components and a power source module. Thepower source module includes a nonhermetic battery. An electricalconductor delivers power from the nonhermetic battery to the components.A means for substantially impeding movement of substances from thenonhermetic battery to the components is included in the implantablemedical device.

In another embodiment, the invention is directed to an implantablemedical device comprising a control module and a power source module.The control module includes a control module housing and componentswithin the control module housing. The power source module includes apower source module housing and a nonhermetic battery within the powersource module housing. An interconnect member couples the control moduleand the power source module. An electrical conductor extends through theinterconnect member from the nonhermetic battery to the components todeliver power from the nonhermetic battery to the components.

In a further embodiment, the invention is directed to a method ofmanufacturing an implantable medical device. The method comprisesforming a control module including components and forming a controlmodule housing to house the components. The method further comprisesforming a power source module including a nonhermetic battery andforming a power source module housing to house the nonhermetic battery.The method also comprises forming an interconnect member to couple thecontrol module and the power source module. The interconnect memberincludes an electrical conductor that extends through the interconnectmember to deliver power from the nonhermetic battery to the components.

The invention may be capable of providing one or more advantages. Forexample, a barrier that substantially impedes movement of substancesfrom the nonhermetic battery to the components allows the nonhermeticbattery to be used safely within the IMD. One or more barriers block,absorb, and/or dissipate the corrosive compounds included in thesubstances, thereby preventing damage to the components and harm to thepatient in which the IMD is implanted.

The nonhermetic battery within the IMD may provide a number ofadvantages relative to a hermetic battery. For example, the nonhermeticbattery may permit significant reductions in the thickness of the powersource module housing and the overall profile of the IMD as well as areduction in the overall size of the IMD. The reduced size and profilethickness allows the IMD to be more cosmetically appealing, comfortable,and clinically acceptable when implanted within a patient. Inparticular, the IMD may create a much smaller and less noticeableprotrusion when implanted in the patient, and may reduce the likelihoodof skin erosion above the implanted IMD. In addition, the nonhermeticbattery may have increased longevity and energy density per cubiccentimeter when compared to hermetic batteries.

The thin nonhermetic battery may also increase packaging efficiency. Amuch larger choice of materials are available for the nonhermeticbattery than for a hermetic battery. A wider variety of battery formfactors are also possible, including the potential to use a foil-packflexible battery. The reduced packaging and variety of material choicesassociated with the nonhermetic battery significantly reduces the costof manufacturing the IMD, potentially by as much as ten times relativeto some existing IMDs.

The details of one or more embodiments of the invention are set forth inthe accompanying drawings and the description below. Other features,objects, and advantages of the invention will be apparent from thedescription and drawings, and from the claims.

BRIEF DESCRIPTION OF DRAWINGS

FIG. 1 is a conceptual diagram illustrating an example implantablemedical device (IMD) implanted on a cranium of a patient.

FIG. 2 is a top-view diagram further illustrating the IMD from FIG. 1implanted on the cranium of the patient.

FIG. 3 is a top-view diagram further illustrating a modular IMD.

FIG. 4 is a block diagram illustrating a control module of the modularIMD from FIG. 3.

FIG. 5 is a block diagram illustrating a power source module of themodular IMD from FIG. 3.

FIGS. 6-11 are block diagrams illustrating example IMDs includingbarriers to substantially impede movement of substances from anonhermetic battery in accordance with various embodiments of theinvention.

FIG. 12 is a block diagram illustrating a top view of another exampleIMD.

DETAILED DESCRIPTION

FIG. 1 is a conceptual diagram illustrating an example implantablemedical device (IMD) 10 that includes a power source module and anonhermetic battery housed within a power source module housing. Thenonhermetic battery may reduce a thickness and overall size of the powersource module housing and thereby reduce a profile of IMD 10. Thereduced profile allows IMD 10 to be more cosmetically appealing,comfortable, and clinically acceptable when implanted, for example, onthe cranium 12 of a patient 14. Other embodiments of IMD 10 permit thedevice to be implanted at many other locations within the body ofpatient 14 that do not present an adequate profile for conventionalimplantable medical devices.

The nonhermetic battery may provide advantages beyond the reducedprofile of IMD 10. For example, compared to a hermetic battery, thenonhermetic battery expands the material and form factor choicesavailable for the power source module housing. Increased packagingefficiency and the ability to select less expensive materials allows thenonhermetic battery to significantly reduce the cost of manufacturingIMD 10. In addition, the nonhermetic battery increases longevity andenergy density per cubic centimeter.

In general, a nonhermetic battery is built to perform substantiallysimilar to a hermetic battery. For example, a nonhermetic battery mayinitially perform just as well in a helium leak test as a hermeticbattery. However, unlike hermetic batteries which have enclosures thatinclude welded, glassed, or braised seals, nonhermetic batteriestypically have enclosures that include crimped seals. Over time, thecrimped seals have a tendency to break down and leak substances, such asvaporized organic solvents, gasses produced during operation of thebattery, and liquid electrolytes including salts.

The substances that may leak from the nonhermetic battery may containcorrosive compounds harmful to IMD 10 and patient 14. IMD 10 includes abarrier to substantially impede the movement of substances from thenonhermetic battery to components in IMD 10. The barrier ensures thatthe substances from the nonhermetic battery will not harm patient 14 inwhich IMD 10 is implanted and will not damage the components. In someembodiments, the components comprise control electronics that controlthe functioning of the IMD. Several embodiments of the barrier will bedescribed in greater detail below.

The nonhermetic battery can be applied within an IMD of any structure.For purposes of illustration, however, the invention will be describedherein as a modular IMD housed in a member that at least partiallyencapsulates one or more housings of the modules and, and generallyserves to provide a smooth interface between the modules and the bodytissue. As will be described in greater detail below, IMD 10 comprises aplurality of separately housed and flexibly interconnected modules. Bydistributing components of IMD 10 among modules rather than includingthem within a single, rigid housing, the IMD may be shaped andconfigured for implantation at locations within patient 14 for whichimplantation of conventional IMDs is deemed undesirable or inapplicable.Further, the flexibility of the interconnection between modules of IMD10 may allow multiples degrees of freedom of movement between themodules, which in turn may allow the implantable medical device toconform to such areas, and in particular embodiments, to conform tosurfaces within patient 14 such as the surface of cranium 12.

In the illustrated example, modular IMD 10 is coupled to two leads 16Aand 16B (collectively “leads 16”) that extend through holes withincranium 12, and into the brain of patient 14. In exemplary embodiments,each of leads 16 carries a plurality of electrodes, and IMD 10 deliversstimulation to the brain of patient 14 via the electrodes. Modular IMD10 may be coupled to any number of leads 16, and in some embodiments isnot coupled to any leads 16. In some embodiments, for example, IMD 10may carry integrated electrodes.

Because modular IMD 10 can be implanted on cranium 12 of patient 14rather then more remotely from the brain of patient 14, such as within asubclavicular region of patient 14, the problems associated with the useof long leads needed to allow a remotely implanted IMD to access thebrain may be diminished or avoided. These problems include therequirement of tunneling under the scalp and the skin of the neck,increased surgery and recovery time, an additional procedure undergeneral anesthesia, risk of infection or skin erosion along the trackthrough which the leads are tunneled, and risk of lead fracture due totorsional and other forces caused by normal head and neck movements.

FIG. 2 is a top-view diagram further illustrating IMD 10 implanted oncranium 12 of the patient 14. In order to implant modular IMD 10 oncranium 12, an incision 20 is made through the scalp of patient 14, anda resulting flap of skin is pulled back to expose the desired area ofcranium 12. The incision may, as shown in FIG. 2, be generally shapedlike a “C.” Such an incision is commonly referred to as a “C-flap”incision.

Holes 22A and 22B (collectively “holes 22”) are drilled through cranium12, and leads 16 are inserted through holes 22 and into the brain ofpatient 14. Caps such as burr hole caps may be placed over holes 22 asis known in the art. Leads 16 are connected to modular IMD 10, eitherdirectly or via a lead extension, and modular IMD 10 is placed at leastpartially within a pocket formed using a hand or a tool beneath thescalp behind holes 22.

Once positioned as desired on cranium 12 within the pocket, modular IMD10 may then be fixed to cranium 12 using an attachment mechanism such asbone screws. The skin flap may be closed over modular IMD 10, and theincision may be stapled or sutured. The location on cranium 12 at whichIMD 10 is illustrated as implanted in FIG. 2 is merely exemplary, andIMD 10 can be implanted anywhere on the surface of cranium 12.

Because of the flexibility that may be provided by interconnect membersof IMD 10 and/or a member of IMD 10 that at least partially encapsulatesthe modules of IMD 10 and provides a smooth interface between themodules and body tissue, the IMD may be manipulated during implantationsuch that it conforms to cranium 12. For example, in some embodiments asurgeon can manipulate modular IMD 10 into conformance with cranium 12while IMD 10 is on cranium 12 and fix modular IMD 10 into place usingbone screws or the like. In other embodiments, the clinician maymanipulate modular IMD 10 into conformance with cranium 12 with IMD 10on and/or off of cranium 12, and IMD 10 may substantially retain theform into which it is manipulated.

As mentioned above, modular IMD 10 may deliver stimulation to the brainof patient 14 to, for example, provide deep brain stimulation (DBS)therapy, or to stimulate the cortex of the brain. Cortical stimulationmay involve stimulation of the motor cortex. Modular IMD 10 may be usedto treat any nervous system disorder including, but not limited to,epilepsy, pain, psychological disorders including mood and anxietydisorders, movement disorders (MVD), such as, but not limited to,essential tremor, Parkinson's disease, and neurodegenerative disorders.

However, modular IMD 10 is not limited to delivery of stimulation to thebrain of patient, and may be employed with leads 16 deployed anywhere inthe head or neck including, for example, leads deployed on or near thesurface of the skull, leads deployed beneath the skull such as near oron the dura mater, leads placed adjacent cranial or other nerves in theneck or head, or leads placed directly on the surface of the brain.Moreover, modular IMD 10 is not limited to implantation on cranium 12.Indeed, modular IMD 10 may be implanted anywhere within patient 14. Forexample, modular IMD 10 can be implanted within the neck of patient 14,and deliver stimulation to the vagus nerve or the cervical region of thespinal cord.

Modular IMD 10 may alternatively be implanted within a pectoral regionor the abdomen of patient 14 to act as a diaphragmatic pacer, or toprovide any of the monitoring and therapy delivery functions known inthe art to be associated with cardiac pacemakers. Further, modular IMD10 may be implanted in the upper buttock region and deliver spinal cord,urological or gastrological stimulation therapy, or may be configured tobe implanted within the periphery, e.g., limbs, of patient 14 fordelivery of stimulation to the muscles and/or peripheral nervous systemof patient 14. Additional implant locations may include the abdomen,e.g., for gastric stimulation. As is the case with cranium 12, themodularity of IMD 10 may enable implantation at some of these examplelocations for which implantation of conventional IMDs is generallydeemed undesirable.

Modular IMD 10 is not limited to embodiments that deliver stimulation.For example, in some embodiments modular IMD 10 may additionally oralternatively monitor one or more physiological parameters and/or theactivity of patient 14, and may include sensors for these purposes.Where a therapy is delivered, modular IMD 10 may operate in an open loopmode (also referred to as non-responsive operation), or in a closed loopmode (also referred to as responsive). Modular IMD 10 may also providewarnings based on the monitoring.

As discussed above, the ability of a modular IMD 10 according to theinvention to be implanted close to a region within patient 14 to bemonitored enables the use of shorter leads 16. Shorter leads 16 mayadvantageously improve the accuracy of such sensors by reducing noiseattributable to leads 16. Shorter leads 16 may also advantageouslyreduce the negative affects of imaging techniques such as magneticresonance imaging “MRI” on a person implanted with IMD 10. Within an MRImachine, leads act as antennas positioned very close to an antennatower, therefore using shorter leads 16 reduces an amount of energyinduced onto IMD 10 from the MRI machine.

Further, in some embodiments modular IMD 10 can additionally oralternatively deliver a therapeutic agent to patient 14, such as apharmaceutical, biological, or genetic agent. Modular IMD 10 may becoupled to a catheter, and may include a pump to deliver the therapeuticagent via the catheter.

FIG. 3 is a top-view diagram further illustrating modular IMD 10. In theillustrated embodiment, modular IMD 10 includes three modules: a controlmodule 30, a power source module 32, and a recharge module 34. As shownin FIG. 3, modules 30, 32 and 34 include separate housings 36, 38 and40, respectively.

Control module 30 includes components within the housing. In someembodiments, the components comprise control electronics, e.g.,electronics that control the monitoring and/or therapy deliveryfunctions of modular IMD 10, such as a microprocessor. Control module 30may also include circuits for telemetry communication with externalprogrammers or other devices within the housing. Housing 36 of controlmodule 30 may be hermetic in order to protect the components therein,and in exemplary embodiments is formed of a rigid material, such astitanium, stainless steel, or a ceramic. In exemplary embodiments,housing 36 is a low-profile, concave housing to substantially conform toa patient's cranium.

Power source module 32 includes a nonhermetic battery. A nonhermeticbattery is a battery contained within a nonhermetic housing or othernonhermetic enclosure, e.g., a housing or enclosure, as described above.The nonhermetic battery is then further housed within housing 38. Thenonhermetic battery provides power for components of other modules, suchas the components within control module 30. The nonhermetic battery maybe any nonhermetic battery suitable for use within an IMD. In anexemplary embodiment, the nonhermetic battery comprises a rechargeableLithium Ion battery with a flexible foil pack construction to moreeasily fit within housing 38, which may be less than approximately 5millimeters thick in a direction normal to a major plane of the housing.The major plane of housing 38 may include an approximately one squareinch (6.5 square centimeters) surface area. Housing 38 may be hermetic,and may be formed of titanium, stainless steel, or a ceramic. Powersource module 32 may include an insulator within housing 38 toelectrically isolate housing 38 from the nonhermetic battery.

Including the nonhermetic battery in power source module 32 reduces athickness and overall size of housing 38, which may then reduce aprofile of IMD 10. The low profile of IMD 10 permits IMD 10 to bedeployed effectively, comfortably and cosmetically within patient 14. Inone embodiment of the invention, IMD 10 including the nonhermeticbattery has a maximum thickness of between approximately 1 millimeterand approximately 5 millimeters. The use of a reduced profile may reducethe risk of infection, skin erosion and cosmetic issues related to theimplantation of IMD 10.

Where the nonhermetic battery comprises a rechargeable nonhermeticbattery, modular IMD 10 may include recharge module 34. Recharge module34 includes a recharge coil (not shown) within housing 40. The rechargecoil inductively receives energy from an external recharging unit (notillustrated) through the skin of patient 14 to recharge the nonhermeticbattery. The recharge coil may be formed of windings of copper oranother highly conductive material. Housing 40 need not be hermetic, andmay be formed of materials such as silicone, polymers and ceramics.

Housings 36, 38 and 40 may have any shape, including the round, coinshape and rectangular shapes with rounded edges illustrated in FIG. 3.Further, one or more surfaces of one or more of housings 36, 38 and 40may be concave along at least one axis, and preferably two axes.

Modules 30, 32 and 34 can be configured in a variety of ways, and theconfiguration illustrated in FIG. 3 is merely exemplary. Further,modular IMD 10 can include any number of modules, and may include othertypes of modules instead of or in addition to a control module 30 and arecharge module 34. For example, modular IMD 10 can include a modulewithin another module, such as power source module 32 within controlmodule 30. In addition, modular IMD 10 can include additional powersource modules, modules that include additional memory that isaccessible by the components, modules that include reservoirs forstoring therapeutic agents and pumps for delivering therapeutic agentsto patient 14, and modules that include sensors sensing physiologicalparameters, such as pressures or blood flows, or the activity level ofpatient 14.

Power source module 32 is coupled to control module 30 by a flexibleinterconnect member 44, which encloses an electrical conductor thatallows transmission of energy from the nonhermetic battery of powersource module 32 to components such as the components within controlmodule 30. In embodiments where energy is transferred via a DC voltageon the electrical conductor, it may be necessary to make flexibleinterconnect member 44 hermetic. In embodiments in which flexibleinterconnect member 44 is hermetic, flexible interconnect member 44 maybe made of titanium, stainless steel, or nitinol. In embodiments whereenergy is transferred via a charge-balance voltage on the electricalconductor, such as an AC voltage, flexible interconnect member 44 neednot be hermetic, and may be made of any material including silicone orvarious polymers.

In the illustrated embodiment, the components of control module 30regulate the recharging and discharging of the nonhermetic batterywithin power source module 32. Consequently, as shown in FIG. 3,recharge module 34 is coupled to control module 30 by a flexibleinterconnect member 46 that encloses an electrical conductor that allowstransmission of energy inductively received by the recharge coil withinrecharge module 34 to control module 30. Because the energy istransferred on the electrical conductor via a charge-balanced voltage,flexible interconnect member 46 need not be hermetic, and may be made ofany material including titanium, stainless steel, nitinol, ceramics,silicone or various polymers.

Interconnect members 44 and 46 are flexible. In some embodiments, asindicated above, interconnect members 44 and 46 are made of a flexiblematerial such as silicone, a flexible polymer, or nitinol. Inembodiments where flexible member 44 is hermetic and made of asubstantially less flexible material, such as titanium or stainlesssteel, the flexibility of interconnect member 44 is provided by theconfiguration and/or construction of flexible interconnect member 44.

Interconnect member 44 is flexible in a plurality of directions toprovide modules 30 and 32 with multiple degrees of freedom of motionwith respect to each other. In exemplary embodiments, interconnectmember 44 provides at least three degrees of motion, and the degrees ofmotion provided include rotational motion.

As shown in FIG. 3, modular IMD 10 includes a member 48, which may beflexible and made of a soft biocompatible material. Member 48 at leastpartially encapsulates one or more of housings 36, 38 and 40, andgenerally serves to provide a smooth interface between the modules andthe body tissue. Member 48 may integrate modules 30, 32 and 34 into adesired form factor, but, where flexible, allow relative intermodulemotion. In some embodiments, member 48 incorporates mechanical featuresto restrict intermodule motion to certain directions or within certainranges. Member 48 may be made from silicone, and in some embodiments maybe made from two or more materials of differing flexibility, such assilicone and a polyurethane. An exemplary polyurethane for this purposeis Tecothaneg, which is commercially available from Hermedics PolymerProducts, Wilmington, Mass. Member 36 may also be referred to as an“overmold,” but use of the term “overmold” herein is not intended tolimit the invention to embodiments in which member 36 is a moldedstructure. Member 36 may be a molded structure, or may be a structureformed by any process.

Member 48 can be shaped to contour to cranium 12, e.g., may be concavealong at least one axis, and may be contoured at its edges to preventskin erosion on the scalp of patient 14. The flexibility and shape ofmember 48 may, in some embodiments, improve the comfort and cosmeticappearance of modular IMD 10 under the scalp, and may make IMD 10 moreclinically acceptable by, for example, reducing the likelihood of skinerosion.

In the illustrated embodiment, modular IMD 10 also includes leadconnector modules 50A and 50B (collectively “lead connector modules 50”)formed within member 48 to receive leads 16 or lead extensions coupledto leads 16. Conductors 52 extend from lead connector modules 50 tohermetic feedthroughs (not illustrated) within housing 36 of controlmodule 30. Lead connector modules 50 may be formed anywhere withinmember 48. In embodiments where member 48 includes a rigid material inaddition to a flexible material, the rigid material may form at leastpart of lead connector modules 50 to secure leads 16 or lead extensions,and to protect conductors 52 from damage that may result from flexingwithin member 48.

FIG. 4 is a block diagram illustrating control module 30 of modular IMD10. As described above, control module 30 includes components, such ascontrol electronics that control the functioning of modular IMD 10within housing 36. The components include a processor 60, which may takethe form of a microprocessor, digital signal processor (DSP),application specific integrated circuit (ASIC), field-programmable gatearray (FPGA), or other logic circuitry.

Control module 30 also includes a memory 62, such as a read-only memory(ROM), random access memory (RAM), electronically-erasable programmableROM (EEPROM), flash memory, or the like. Memory 62 may store programinstructions that may be executed by processor 60 and thereby controlthe functioning of modular IMD 10. Processor 60 may also store datacolleted during treatment and/or monitoring of patient 14 within memory62.

In some embodiments, control module 30 includes telemetry circuitry 64,which enables processor 60 to communicate with other devices such as anexternal programming device via radio-frequency communication. Telemetrycircuitry 64 may include a telemetry coil (not illustrated), which maybe fabricated of windings of copper or another highly conductivematerial. The configuration and location of the telemetry coil withinhousing 36 may be dictated by the available space within housing 36 andthe communication requirements of telemetry circuitry 64.

In some embodiments, modular IMD 10 delivers electrical stimulation, andmore particularly, control module 30 includes therapy delivery circuitry66 within housing 36 that generates electrical stimulation. In exemplaryembodiments, therapy delivery circuitry 66 comprises circuits for thegeneration of electrical stimulation in the form of pulses, such ascapacitors and switches. In embodiments in which modular IMD 10 is aneurostimulator coupled to leads 16 that include a plurality ofelectrodes, therapy delivery circuitry 66 may deliver the pulses to aswitch matrix 68, which comprises an array of switches. In suchembodiments, processor 60 interacts with switch matrix 68 to selectelectrodes for delivery of generated stimulation pulses. Based on theselections made by processor 60, switch matrix 68 delivers the pulses toconductors that pass through feedthroughs in housing 36 and toelectrical contacts on leads 16 that are electrically coupled to thedesired electrodes carried by leads 16.

The illustrated components of control module 30 receive energy from thenonhermetic battery within power source module 32 via interconnectmember 44 (FIG. 3). In some embodiments in which the nonhermetic batteryis rechargeable, control module 30 receives energy inductively capturedby recharge module 34 via interconnect member 46, and includes powermanagement circuitry 70 that controls the recharging and discharging ofthe nonhermetic battery. Power management circuitry 70 may ensure thatthe nonhermetic battery is not overcharged, over-discharged, or harmed.In some embodiments, power management circuitry 70 includes circuits tomeasure voltages, currents or temperatures associated with thenonhermetic battery, or rates of change of these parameters, andcontrols recharging and discharging according to the measured values.Power management circuitry 70 may also include circuits, such asrectifier circuits, for converting charge-balanced voltages, e.g., ACvoltages, provided by a recharge coil (not shown) into net DC voltagesfor recharging the nonhermetic battery.

FIG. 5 is a block diagram illustrating power source module 32 of modularIMD 10. Power source module 32 includes a rechargeable nonhermeticbattery 72 within housing 38. In the illustrated embodiment in whichpower source module 32 directly receives energy inductively captured byrecharge module 34 via flexible interconnect member 44, power sourcemodule 32 also includes power management circuit 74 that controls therecharging and discharging of nonhermetic battery 72. As described abovewith reference to power management circuitry 70 of control module 30illustrated in FIG. 4, power management circuitry 74 may ensure thatnonhermetic battery 72 is not overcharged, over-discharged, or harmed.In some embodiments, power management circuitry 74 includes circuits tomeasure voltages, currents or temperatures associated with nonhermeticbattery 72, or rates of change of these parameters, and controlsrecharging and discharging of nonhermetic battery 72 according to themeasured values.

Power management circuitry 74 may also include circuits, such asrectifier circuits, for converting charge-balanced voltages, e.g., ACvoltages, provided by a recharge coil (not shown) into DC voltages forrecharging nonhermetic battery 72. In some embodiments in whichinterconnect member 44 is nonhermetic, power management circuitry 74includes modulating circuits, i.e., circuits that enable powermanagement circuit 74 to deliver energy to control module 30 in the formof charge-balanced voltages on an electrical conductor. In suchembodiments, control module 30 includes circuits, such as rectifiercircuits, to convert the charge-balanced voltages to DC voltages for useby components of control module 30.

FIGS. 6-11 are block diagrams illustrating example IMDs includingbarriers, in accordance with embodiments of the invention, thatsubstantially impede movement of substances from a nonhermetic batteryto components within the example IMDs. In some embodiments, thecomponents comprise control electronics. The substances from thenonhermetic battery may contain corrosive compounds, such as vaporizedorganic solvents, gasses produced during operation of the battery, andliquid electrolytes including salts. The barriers impede the movement ofsubstances from the nonhermetic battery to the components so that thecorrosive compounds cannot cause damage. The damage would not only beharmful to the IMD, but could potentially be harmful to a patient inwhom the IMD is implanted. For example, the substances from thenonhermetic battery that contain corrosive compounds may enter thepatient's body. In addition, the damaged IMD may malfunction, e.g.,abruptly quit delivering therapy or deliver inappropriate therapy to thepatient.

The example IMDs may operate substantially similar to IMD 10 describedabove. Each of the barriers may be used individually or in combinationwith one another. For purposes of illustration, each of the IMDsillustrated in FIGS. 6-11 comprises one electrical conductor between thenonhermetic battery and the components. Typically, at least twoelectrical conductors are included to allow electrical isolation betweena housing of the nonhermetic battery and a case of the IMD. In that way,the case of the IMD may be used as an electrical element for interactionwith an electrode, for example. Again, the invention may be included inan IMD of any structure, but will be described herein as embodied withina modular IMD.

FIGS. 6A and 6B are block diagrams illustrating a top view and a sideview, respectively, of an example IMD 78. IMD 78 includes a power sourcemodule 80 that includes a power source module housing 81 and anonhermetic battery 84 within power source module housing 81.Additionally, IMD 78 further includes a control module 82 that includesa control module housing 83 and components 86 within control modulehousing 83. An electrical conductor 88 extends from nonhermetic battery84 to components 86 and delivers power from nonhermetic battery 84 tocomponents 86. Power source module 80 and control module 82 are coupledvia an interconnect member 90, through which conductor 88 extends.

IMD 78 comprises a hermetic feedthrough 92 that acts as a barrier tosubstantially impede movement of substances, such as vaporized organicsolvents, gasses produced during operation of the battery, and liquidelectrolytes including salts, from nonhermetic battery 84 to components86. Electrical conductor 88 extends through hermetic feedthrough 92between nonhermetic battery 84 and components 86. As shown in FIGS. 6Aand 6B, hermetic feedthrough 92 is positioned at an interface area 93where power source module 80 and interconnect member 90 couple to eachother. In that way, hermetic feedthrough 92 may ensure that no corrosivecompounds included in the substances from nonhermetic battery 84 canleave power source module housing 81. As opposed to a nonhermeticfeedthrough comprising a rivet that, over time, may allow the substancesto leak, a hermetic feedthrough comprises a weld or a braise thatmaintains a substantially permanent air-tight seal.

As hermetic feedthrough 92 blocks the movement of substances fromreaching components 86, at least a portion of hermetic feedthrough 92 isexposed to the corrosive compounds within the substances. The exposedportion of hermetic feedthrough 92 may be subject to corrosive effects,especially at contact points with power source module housing 81 andnonhermetic battery 84. Therefore, in order to connect hermeticfeedthrough 92 to the positive pole of nonhermetic battery 84, aselected pin material must be able to avoid corrosion. For example, aNiobium pin may be prone to corrosion, but suitable corrosion-resistantpin materials may include Ti-6V-4Al, aluminum, or molybdenum. Inaddition, hermetic feedthrough 92 may comprise a suitablecorrosion-resistant feedthrough glass material, such as Cabal-12.

In the illustrated embodiment, only one hermetic feedthrough 92 is used.Therefore, interconnect module 90 is a conductor in electrical contactwith one of the poles of nonhermetic battery 84. In other embodiments,additional hermetic feedthroughs may be included in IMD 78. For example,if two hermetic feedthroughs are used, interconnect member 90 can beelectrically insulated from nonhermetic battery 84. Additionalfeedthroughs may also be used to connect control module 82 to sensors inpower source module 80. The sensors may detect temperature or, in thecase of a voltage reference electrode, battery status.

Hermetic feedthrough 92 forms a part of power source module housing 81.However, hermetic feedthrough 92 in power source module housing 81causes interface area 93 and interconnect member 90 to comprisethicknesses at least as thick as an outside cross-sectional area ofhermetic feedthrough 92. As shown in FIG. 6B, power source modulehousing 81 remains thin until interface area 93. The illustratedembodiment allows IMD 78 to have a maximum thickness of betweenapproximately 3 millimeters and approximately 8 millimeters.

FIGS. 7A and 7B are block diagrams illustrating a top view and a sideview, respectively, of another example IMD 94. IMD 94 includes a powersource module 96 that includes a power source module housing 97 and anonhermetic battery 100 within power source module housing 97.Additionally, IMD 94 further includes a control module 98 that includesa control module housing 99 and components 102 within control modulehousing 99. An electrical conductor 104 extends from nonhermetic battery100 to components 102 and delivers power from nonhermetic battery 100 tocomponents 102. Power source module 96 and control module 98 are coupledvia an interconnect member 106, through which conductor 104 extends.

IMD 94 comprises a hermetic feedthrough 108 that acts as a barrier tosubstantially impede movement of substances from nonhermetic battery 100to components 102. Electrical conductor 104 extends through hermeticfeedthrough 108 between nonhermetic battery 100 and components 102. Asshown in FIGS. 7A and 7B, hermetic feedthrough 108 is positioned at aninterface area 109 where interconnect member 106 and control module 98couple to each other. In that way, hermetic feedthrough 108 may ensurethat no corrosive compounds included in the substances from nonhermeticbattery 100 can enter control module housing 99. Hermetic feedthrough108 may be substantially similar to hermetic feedthrough 92 described inreference to FIGS. 6A and 6B.

Hermetic feedthrough 108 forms a part of control module housing 99.However, hermetic feedthrough 108 in control module housing 99 causesinterface area 109 of interconnect member 106 to comprise a thickness atleast as thick as an outside cross-sectional area of hermeticfeedthrough 92. As shown in FIG. 7B, power source module housing 97 andinterconnect member 106, until interface area 109, comprise thicknessesless than an outside area of hermetic feedthrough 108. The illustratedembodiment allows IMD 94 to have a maximum thickness of betweenapproximately 3 millimeters and approximately 8 millimeters

In addition to the positions of hermetic feedthroughs 92 and 108described above, a hermetic feedthrough may be located at any positionalong an interconnect member, such as interconnect member 106. Theinterconnect member may be constructed in two sections joined togetherby, for example, welding. Movement of substances from a nonhermeticbattery may subject the welded areas of the interconnect member tocorrosive effects. The hermetic feedthrough may be positioned betweenthe two sections to block the movement of substances from damaging thewelded areas of the interconnect member and components within the IMD.

FIG. 8 is a block diagram illustrating a top view of an example IMD 110.IMD 110 includes a power source module 112 that includes a power sourcemodule housing 113 and a nonhermetic battery 116 within power sourcemodule housing 113. Additionally, IMD 110 further includes a controlmodule 114 that includes a control module housing 115 and components 118within control module housing 115. An electrical conductor 120 extendsfrom nonhermetic battery 116 to components 118 and delivers power fromnonhermetic battery 116 to components 118. Power source module 112 andcontrol module 114 are coupled via an interconnect member 122, throughwhich conductor 120 extends.

IMD 110 comprises a first seal member 124 and a second seal member 126that act as barriers to substantially impede movement of substances fromnonhernetic battery 116 to components 118. First seal member 124 ispositioned within interconnect member 122 where interconnect member 122couples to power source module 112. First seal member 124 blocks themovement of substances from leaving the power source module housing 113.Second seal member 126 is positioned within interconnect member 122where interconnect member 122 couples to control module 114. Second sealmember 126 blocks the movement of substances from entering the controlmodule housing 115. In embodiments where interconnect member 122comprises a cylindrical shape, first and second seals 124, 126 maycomprise o-ring, gasket, or grommet seals. In some embodiments, only oneof the first and second seal members is included within IMD 110. Inother embodiments, a plurality of seal members may be positioned at aplurality of locations within IMD 110.

First and second seals 124, 126 may comprise materials with lowpermeability and high creep resistance. For example, these materials maybe cross-linked crystalline materials that are either rigid orelastomeric. A partial list of rigid materials includes polypropylene,high density polyethylene, polyester, and engineering plastics such aspolymers containing ether ketones (PEK, PEEK), polyether imide (PEI),polyamide imide (PAI), polyphenylene oxide (PPO), polyether sulfone(PES), and polyphenylene sulfide (PPS). A partial list of elastomersincludes EPDM (ethylene-propylene-dieneterpolymer), isoprene,polyurethanes, silicones, and thermoplastic elastomers (TPE) such asstyrenic block copolymers (SBC), thermoplastic olefins (TPO), andcopolyesters (COPE). Examples of TPE trade names include Kraton®,Dynaflex®, Versaflex®, Versalloy® and Versollan™ from Dynaflex Corp.,Grand Rapids, Mich.

FIG. 9 is a block diagram illustrating a top view of an example IMD 128.IMD 128 includes a power source module 130 that includes a power sourcemodule housing 131 and a nonhermetic battery 134 within power sourcemodule housing 131. Additionally, IMD 128 further includes a controlmodule 132 that includes a control module housing 133 and components 136within control module housing 133. An electrical conductor 138 extendsfrom nonhermetic battery 134 to components 136 and delivers power fromnonhermetic battery 134 to components 136. Power source module 130 andcontrol module 132 are coupled via an interconnect member 140, throughwhich conductor 138 extends. Interconnect member 140 may define a voidthrough which electrical conductor 138 extends.

The void of interconnect member 140 is filled with a material 141 tosubstantially impede movement of substances from nonhermetic battery 134to components 136. In some embodiments, the interconnect member void isonly partially filled with material 141. Material 141 may be one ofbackfilled, flowed, and inserted into the void of interconnect member140. In the case where material 141 is inserted into the void, material141 may be manipulated after insertion to create a substantiallypermanent air-tight seal with interconnect member 141. Material 141 issubstantially impermeable to the substances from nonhermetic battery134. Therefore, material 141 blocks corrosive compounds within thesubstances from reaching components 136 and potentially damaging IMD 128and injuring a patient in which IMD 128 is implanted. Material 141 mayalso be flexible to allow interconnect member 140 to bend and flex, asdescribed above.

A suitable material 141 may include a thermoplastic polymer such aspolyolefin or ethylvinyl acetate. Material 141 may also comprise athermosetting resin introduced to interconnect member 140 in a liquid ormolten state and cured after filling. Examples of thermosetting resinsinclude epoxies, silicones, polyurethanes, and isocyanates. It isadvantageous to have material 141 comprise a material that expands, orat least minimally contracts, upon solidification. In that case, anotherexample of material 141 may comprise a closed-cell foam that forms a gasupon curing such as isocyanate-terminated polyurethanes and acryliclatex polymers. Isocyanates, which have the property of forming strongbonds to metals such as aluminum, are therefore useful for forming atight, permanent seal within interconnect member 140.

Material 141 may also include fillers that may be in a finely dividedform such as flakes or powders. Fillers may either impart lowpermeability or absorption of the substances from nonhermetic battery134. Absorbents may include getters described in more detail below.Materials with low permeability may include minerals, e.g., mica,ceramics, metals, and polymers. Material 141 may comprise anonconductive metal, such as aluminum. If material 141 includes metalsthat would render material 141 electrically conductive, then nonhermeticbattery 134 may require a complete or partial layer of electricalinsulation from material 141. The electrical insulation may be a paint,a conformal coating, a potting compound, a polymer film, a ceramic, anoxide, or a passivation layer.

FIG. 10 is a block diagram illustrating a top view of an example IMD142. IMD 142 includes a power source module 144 that includes a powersource module housing 145 and a nonhermetic battery 148 within powersource module housing 145. Additionally, IMD 142 further includes acontrol module 146 that includes a control module housing 147 andcomponents 150 within control module housing 147. An electricalconductor 152 extends from nonhermetic battery 148 to components 150 anddelivers power from nonhermetic battery 148 to components 150. Powersource module 144 and control module 146 are coupled via an interconnectmember 154, through which conductor 152 extends.

Power source control module 144 includes a material 156 thatsubstantially encapsulates nonhermetic battery 148 within power sourcemodule housing 145. In some embodiments, material 156 may only partiallyencapsulate nonhermetic battery 148. Encapsulating nonhermetic battery148 within material 156 substantially blocks movement of substances fromleaving power source module housing 145. Material 156 is impermeable bycorrosive compounds included in the substances from nonhermetic battery148. The substances typically move out of nonhermetic battery 148 alongtermination wires or joints between sections of a battery case (notshown) or between the battery case and a nonhermetic feedthrough.Specifically designing material 156 to be resistant to the movement ofsubstances from nonhermetic battery 148 at those locations increasescontainment of the corrosive compounds that may harm components 150 anda patient in which IMD 142 is implanted.

In some embodiments, nonhermetic battery 148 may be polymerized in placewithin power source module housing 145 with material 156. In that case,material 156 may comprise a thermosetting plastic, such as silicone,epoxy, or polyester. In other embodiments, material 145 may comprise athermoplastic that, when melted, flows into power source module housing145 to surround nonhermetic battery 148. In that case, material 145 maycomprise a polyolefin, which includes polyethylene and polypropylene. Inaddition, material 145 may comprise one of the materials listed abovefor seal members 124 and 126 (FIG. 8) and material 141 (FIG. 9).

FIG. 11 is a block diagram illustrating a top view of an example IMD158. IMD 158 includes a power source module 160 that includes a powersource module housing 161 and a nonhermetic battery 164 within powersource module housing 161. Additionally, IMD 158 further includes acontrol module 162 that includes a control module housing 163 andcomponents 166 within control module housing 163. An electricalconductor 168 extends from nonhermetic battery 164 to components 166 anddelivers power from nonhermetic battery 164 to components 166. Powersource module 160 and control module 162 are coupled via an interconnectmember 170, through which conductor 168 extends.

The movement of substances may be impeded by a length and/orcross-sectional area of interconnect member 170. A long interconnectmember allows the substances from nonhermetic battery 164 to dissipatebefore reaching components 166. A small interconnect membercross-sectional area increases resistance against the movement to slowthe diffusion rate of the substances from nonhermetic battery 164 tocomponents 166. The ratio of interconnect member length to internal areashould be kept as large as possible to increase diffusional resistance.In an embodiment where interconnect member 170 comprises a cylindricalshape, the ratio of interconnect member length to outside diameter is atleast 10. As an example, an interconnect member length of 3 inches andan outside diameter of 0.05 inch gives a ratio of 60. The interconnectmember ratio may also be applied to any of the IMDs described above.

As shown in FIG. 11, interconnect member 170 is crimped to createreduced-area regions 172 that substantially impede movement ofsubstances from nonhermetic battery 164 to components 166. Crimpinginterconnect member 170 may involve pinching, rolling, drawing, or acombination thereof. In other embodiments, a plurality of reduced-arearegions may be created along the length of interconnect member 170.

In some embodiments, a void defined by interconnect member 170 is atleast partially filled with a material, substantially similar to FIG. 9.Reduced-cross-sectional area regions 172 are created after placing thematerial within the void of interconnect member 170. The materialcreates a pressure seal within interconnect member 170 at eachreduced-cross-sectional area region 172. Refer to FIGS. 8 and 9 for alisting of materials that are only minimally permeable by substancesfrom nonhermetic battery 164, and resistant to creep.

IMD 158 may also include a getter to substantially impede the movementof substances from nonhermetic battery 164 to components 166. The gettermay be located within at least one of power source module 160,interconnect member 170, and control module 162. The getter absorbs orreacts with the substances within IMD 158 to form a solid nonvaporizablematerial or to substantially eliminate the corrosive compounds and/orelements that create corrosive compounds included in the substances fromnonhermetic battery 164. In some embodiments, several getters areincluded in IMD 158. The getter may also be included within any of theIMDs described above.

The getter may comprise a desiccant, or any other type of getter forwater. Common types of desiccants are silica gel or calcium carbonate,silico-aluminate, clay (montmorillonite), and molecular sieve. If PF₆leaks out of nonhermetic battery 164 and water is available, thecompounds will react to produce hydrofluoric acid (HF). However, if nowater is available, no HF can be created. If any HF were to come incontact with components 166, it would damage components 166 andpotentially injure a patient in which IMD 158 is implanted.

The getter may also comprise a getter for HF, such as fumed or gelledsilica because silica is an excellent HF getter. The getter may furthercomprise a getter for organics. For example, the organic getter may be atype of carbon such as activated charcoal. Carbon has the ability to beformed and pressed into a specific shape, which allows the organicgetter to fit in a variety of positions within IMD 158.

The getter may be located anywhere within the volume of IMD 158.Further, the getter may be randomly placed in IMD 158 betweennonhermetic battery 164 and components 166. The getter may also bedirectly incorporated within a material to form elements such as sealmembers, material to fill interconnect member 170, material toencapsulate nonhermetic battery 164, or the like. For example, MultisorbIncorporated of Buffalo, N.Y., USA manufactures desiccants in forms thatmay incorporate easily within IMD 158, including machinable material,hot-melt glue, and plastic films.

In addition, nonhermetic battery 164 may include a gel, polymer, orsolid electrolyte instead of a gas or liquid electrolyte. The gel,polymer, or solid electrolyte acts as a barrier within nonhermeticbattery 164 by substantially eliminating movement of substances fromnonhermetic battery 164. The gel, polymer, or solid electrolyte reducesvapor pressure within nonhermetic battery 164, which reduces a chance ofnonhermetic battery 164 leaking. Furthermore, if nonhermetic battery 164does leak, the gel, polymer, or solid electrolyte has a much smallerchance of leaving nonhermetic battery 164 than a gas or fluidelectrolyte. An electrolyte gelling agent such as polyvinylidenefluoride (PVDF), polyvinylidene fluoride-hexafluoropropylene (PVDF-HFP)copolymer, polyethylene oxide (PEO), silicon, or a mixture thereof, isused to create the gelled electrolyte. The polymer or solid electrolytemay create a thin-film nonhermetic battery. The solid electrolyte maycomprise ceramic or glass. The nonhermetic batteries included in theIMDs described above may also include the gel, polymer, or solidelectrolyte.

In some embodiments, IMD 158 may not include power source module housing160. In that case, nonhermetic battery 164 may couple directly tointerconnect member 170 by a hermetic weld or braise around theconnection area. Sealing the interface area between nonhermetic battery164 and interconnect member 170 substantially blocks the substances fromentering the patient's body. Eliminating the power source module housing160 allows IMD 158 to comprise a further reduced profile thickness. TheIMDs described above may also not include a power source module housingthat fully encapsulates the nonhermetic battery.

FIG. 12 is a block diagram illustrating a top view of another exampleIMD 174. IMD 174 includes a power source module 176 that includes apower source module housing 177 and a nonhermetic battery 180 withinpower source module housing 177. Control module 178 includes a controlmodule housing 179 and components 182 within control module housing 179.Power source module 176 is included within control module housing 179.An electrical conductor 184 extends from nonhermetic battery 180 tocomponents 182 and delivers power from nonhermetic battery 180 tocomponents 178. In some embodiments, components 182 may comprise controlelectronics.

IMD 174 illustrates an IMD set-up as an alternative to the IMDsillustrated in FIGS. 6-11. The illustrated embodiment may correspond toa non-modular IMD. For example, IMD 174 may comprise a conventional IMDwith a single housing that houses substantially all of the IMD'scomponents. The barriers described above may also be applied to IMD 174to block, absorb and/or dissipate the movement of substances betweennonhermetic battery 180 and components 182.

Various embodiments of the invention have been described. For example,an implantable medical device (IMD) including a nonhermetic battery hasbeen described. The nonhermetic battery reduces a profile and amanufacturing cost of the IMD. The IMD also includes a barrier to impedemovement of substances from the nonhermetic battery from reachingcomponents within the IMD and injuring a patient in which the IMD isimplanted. A variety of barriers are described including hermeticfeedthroughs, seal members, material to encapsulate the nonhermeticbattery, chemical getters, and gel, polymer, or solid electrolytes. Amodular IMD is also described that includes an interconnect member tocouple a module including the nonhermetic battery to a module includingthe components. Barriers may also be including in the interconnectmember, such as length, cross-sectional area, and material filling atleast a portion of a void defined by the interconnect member.

Nevertheless, various modifications may be made without departing fromthe scope of the invention. For example, the IMD described above mayinclude any nonhermetic electro-chemical generator, such as a fuel cell,instead of a nonhermetic battery. A fuel cell is designed to vent thesubstances created by operation. The barriers provided by the inventionenable a fuel cell or similar generator to be included in an IMD as thebarriers substantially impede the movement of substances. Furthermore,the components with the IMD may refer to control electronics as well assensor control components and other control mechanisms that may or maynot be included within the control module housing.

These and other embodiments are within the scope of the followingclaims.

1. An implantable medical device comprising: components; a power sourcemodule that includes a nonhermetic battery; an electrical conductor thatdelivers power from the nonhermetic battery to the components; and abarrier between the components and the nonhermetic battery thatsubstantially impedes movement of substances from the nonhermeticbattery to the components.
 2. The implantable medical device of claim 1,wherein the barrier comprises a hermetic feedthrough and the electricalconductor extends through the feedthrough.
 3. The implantable medicaldevice of claim 2, further comprising a power source module housing,wherein the nonhermetic battery is located within the power sourcemodule housing and the hermetic feedthrough forms a part of the powersource module housing.
 4. The implantable medical device of claim 2,further comprising a control module including a control module housing,wherein the components are located within the control module housing andthe hermetic feedthrough forms a part of the control module housing. 5.The implantable medical device of claim 2, wherein the hermeticfeedthrough is exposed to the substances from the nonhermetic batteryand the hermetic feedthrough comprises a corrosion-resistant material.6. The implantable medical device of claim 5, wherein thecorrosion-resistant material includes one of glass and ceramic.
 7. Theimplantable medical device of claim 1, wherein the barrier comprises aseal member.
 8. The implantable medical device of claim 7, furthercomprising: a control module including a control module housing, whereinthe components are located within the control module housing; and aninterconnect member to couple the control module and the power sourcemodule, wherein the conductor extends through the interconnect member,wherein the seal member is positioned within the interconnect member oneof where the interconnect member is coupled to the control module andwhere the interconnect member is coupled to the power source module. 9.The implantable medical device of claim 7, wherein the seal membercomprises one of an o-ring, a gasket, or a grommet seal.
 10. Theimplantable medical device of claim 1, further comprising: a controlmodule including a control module housing, wherein the components arelocated within the control module housing; and an interconnect member tocouple the control module and the power source module, wherein theinterconnect member defines a void and the conductor extends through theinterconnect member void, wherein the barrier comprises a material thatfills at least a portion of the interconnect member void.
 11. Theimplantable medical device of claim 10, wherein the material issubstantially impermeable by the substances from the nonhermeticbattery.
 12. The implantable medical device of claim 10, wherein thematerial comprises at least one of a polymer, a resin, a filler, or afinely divided filler.
 13. The implantable medical device of claim 12,wherein the filler substantially blocks the movement of substances fromthe nonhermetic battery.
 14. The implantable medical device of claim 12,wherein the filler substantially absorbs the substances from thenonhermetic battery.
 15. The implantable medical device of claim 10,wherein the interconnect member is crimped to create areduced-cross-sectional area region.
 16. The implantable medical deviceof claim 1, wherein the barrier comprises a material that encapsulatesat least a portion of the nonhermetic battery.
 17. The implantablemedical device of claim 16, wherein the material is substantiallyimpermeable by the substances from the nonhermetic battery.
 18. Theimplantable medical device of claim 16 wherein the material comprisesone of a polymer and a resin.
 19. The implantable medical device ofclaim 1, wherein the barrier comprises a getter.
 20. The implantablemedical device of claim 19, wherein the getter one of substantiallyabsorbs or reacts with the substances from the nonhermetic battery. 21.The implantable medical device of claim 19, wherein the getter comprisesone of a water getter, a salt getter, a hydrofluoric acid getter, or anorganic getter.
 22. The implantable medical device of claim 1, furthercomprising: a power source module housing, wherein the nonhermeticbattery is located within the power source module housing; a controlmodule including a control module housing, wherein the components arelocated within the control module housing; and an interconnect member tocouple the control module and the power source module, wherein theconductor extends through the interconnect member, wherein the barriercomprises a getter within at least one of the power source modulehousing, the interconnect member, or the control module housing.
 23. Theimplantable medical device of claim 1, wherein the barrier comprises oneof a gel, a polymer, or a solid electrolyte within the nonhermeticbattery.
 24. The implantable medical device of claim 23, wherein the oneof the gel, polymer, or solid electrolyte substantially eliminates themovement of substances from the nonhermetic battery.
 25. The implantablemedical device of claim 1, further comprising: a control moduleincluding a control module housing, wherein the components are locatedwithin the control module housing; and an interconnect member to couplethe control module and the power source module, wherein the conductorextends through the interconnect member, wherein the barrier comprises alength and cross-sectional area of the interconnect member.
 26. Theimplantable medical device of claim 25, wherein the interconnect memberis crimped to create a reduced-area region.
 27. The implantable medicaldevice of claim 1, wherein the components comprise control electronics.28. An implantable medical device comprising: components; a power sourcemodule that includes a power source module housing and a nonhermeticbattery within the power source module housing; an electrical conductorthat delivers power from the nonhermetic battery to the components; anda material within the power source module housing that substantiallyimpedes movement of substances from the nonhermetic battery to thecomponents.
 29. The implantable medical device of claim 28, wherein thematerial encapsulates at least a portion of the nonhermetic battery. 30.The implantable medical device of claim 28, wherein the materialcomprises a getter.
 31. The implantable medical device of claim 28,wherein the components comprise control electronics.
 32. An implantablemedical device comprising: components; a power source module thatincludes a nonhermetic battery; an electrical conductor that deliverspower from the nonhermetic battery to the components; and means forsubstantially impeding movement of substances from the nonhermeticbattery to the components.
 33. The implantable medical device of claim32, wherein the means comprises a hermetic feedthrough and the conductorextends through the feedthrough.
 34. The implantable medical device ofclaim 33, further comprising a power source module housing, wherein thenonhermetic battery is located within the power source module housingand the hermetic feedthrough forms a part of the power source modulehousing.
 35. The implantable medical device of claim 33, furthercomprising a control module including a control module housing, whereinthe components are located within the control module housing and thehermetic feedthrough forms a part of the control module housing.
 36. Theimplantable medical device of claim 32, wherein the means comprises aseal member.
 37. The implantable medical device of claim 36, furthercomprising: a control module including a control module housing, whereinthe components are located within the control module housing; and aninterconnect member to couple the control module and the power sourcemodule, wherein the conductor extends through the interconnect member,wherein the seal member is positioned within the interconnect member oneof where the interconnect member is coupled to the control module andwhere the interconnect member is coupled to the power source module. 38.The implantable medical device of claim 36, wherein the seal membercomprises one of an o-ring, a gasket, or a grommet seal.
 39. Theimplantable medical device of claim 32, further comprising: a controlmodule including a control module housing, wherein the components arelocated within the control module housing; and an interconnect member tocouple the control module and the power source module, wherein theinterconnect member comprises a void and the conductor extends throughthe interconnect member void, wherein the barrier comprises a materialthat fills at least a portion of the interconnect member void.
 40. Theimplantable medical device of claim 32, wherein the means comprises amaterial that encapsulates at least a portion of the nonhermeticbattery.
 41. The implantable medical device of claim 32, wherein themeans comprises a getter.
 42. The implantable medical device of claim32, further comprising: a power source module housing, wherein thenonhermetic battery is located within the power source module housing; acontrol module including a control module housing, wherein thecomponents are located within the control module housing; and aninterconnect member to couple the control module and the power sourcemodule, wherein the conductor extends through the interconnect member,wherein the means comprises a getter within at least one of the powersource module housing, the interconnect member, or the control modulehousing.
 43. The implantable medical device of claim 32, wherein themeans comprises one of a gel, polymer, and solid electrolyte within thenonhermetic battery.
 44. The implantable medical device of claim 32,further comprising: a control module including a control module housing,wherein the components are located within the control module housing;and an interconnect member to couple the control module and the powersource module, wherein the conductor extends through the interconnectmember, and wherein the means comprises a length and cross-sectionalarea of the interconnect member.
 45. The implantable medical device ofclaim 44, wherein the interconnect member is crimped to create areduced-cross-sectional area region.
 46. The implantable medical deviceof claim 32, wherein the components comprise control electronics.
 47. Animplantable medical device comprising: a control module that includes acontrol module housing and components within the control module housing;a power source module that includes a power source module housing and anonhermetic battery within the power source module housing; aninterconnect member to couple the control module and the power sourcemodule; and an electrical conductor that extends through theinterconnect member to deliver power from the nonhermetic battery to thecomponents.
 48. The implantable medical device of claim 47, wherein theinterconnect member comprises a length that substantially dissipatesmovement of substances from the nonhermetic battery to the components.49. The implantable medical device of claim 47, wherein the interconnectmember comprises a cross-sectional area that substantially impedesmovement of substances from the nonhermetic battery to the components.50. The implantable medical device of claim 47, wherein the interconnectmember is crimped to create a reduced-cross-sectional area region. 51.The implantable medical device of claim 47, further comprising ahermetic feedthrough through which the electrical conductor extends andthat substantially impedes movement of substances from the nonhermeticbattery to the components.
 52. The implantable medical device of claim51, wherein the hermetic feedthrough forms a part of the power sourcemodule housing.
 53. The implantable medical device of claim 52, whereinan interface area of the power source module housing with theinterconnect member comprises a thickness at least as thick as anoutside cross-sectional area of the hermetic feedthrough.
 54. Theimplantable medical device of claim 51, wherein the hermetic feedthroughforms a part of the control module housing.
 55. The implantable medicaldevice of claim 54, wherein an interface area of the interconnect memberwith the control module housing comprises a thickness at least as thickas an outside cross-sectional area of the hermetic feedthrough.
 56. Theimplantable medical device of claim 51, wherein the power source moduleand the interconnect member comprise thicknesses less than an outsidecross-sectional area of the hermetic feedthrough.
 57. The implantablemedical device of claim 47, further comprising a seal member thatsubstantially impedes movement of substances from the nonhermeticbattery to the components.
 58. The implantable medical device of claim57, wherein the seal member is positioned within the interconnect memberone of where the interconnect member is coupled to the control moduleand where the interconnect member is coupled to the power source module.59. The implantable medical device of claim 57, wherein the seal membercomprises one of an o-ring, a gasket, and a grommet seal.
 60. Theimplantable medical device of claim 47, wherein the interconnect memberdefines a void through which the electrical conductor extends, theimplantable medical device further comprising a material that fills atleast a portion of the interconnect member void and substantiallyimpedes movement of substances from the nonhermetic battery to thecomponents.
 61. The implantable medical device of claim 47, furthercomprising a material that encapsulates at least a portion of thenonhermetic battery within the power source module housing and thatsubstantially impedes movement of substances from the nonhermeticbattery to the components.
 62. The implantable medical device of claim47, further comprising a getter within at least one of the power sourcemodule housing, the interconnect member, or the control module housingthat substantially impedes movement of substances from the nonhermeticbattery to the components.
 63. The implantable medical device of claim47, further comprising one of a gel, polymer, and solid electrolytewithin the nonhermetic battery that substantially eliminates movement ofsubstances from the nonhermetic battery to the components.
 64. Theimplantable medical device of claim 47, wherein the components comprisecontrol electronics.
 65. A method of manufacturing an implantablemedical device, the method comprising: forming a control moduleincluding components; forming a control module housing to house thecomponents; forming a power source module including a nonhermeticbattery; forming a power source module housing to house the nonhermeticbattery; and forming an interconnect member to couple the control moduleand the power source module, the interconnect member including anelectrical conductor that extends through the interconnect member todeliver power from the nonhermetic battery to the components.
 66. Themethod of claim 65, further comprising housing the nonhermetic batterywithin a nonhermetic housing included in the power source modulehousing.
 67. The method of claim 65, wherein the implantable medicaldevice includes a barrier between the components and the nonhermeticbattery that substantially impedes movement of substances from thenonhermetic battery to the components.
 68. The method of claim 67,wherein the barrier comprises a hermetic feedthrough.
 69. The method ofclaim 67, wherein the barrier comprises a length and cross-sectionalarea of the interconnect member.
 70. The method of claim 67, wherein thebarrier comprises a seal member positioned within the interconnectmember one of where the interconnect member is coupled to the controlmodule and where the interconnect member is coupled to the power sourcemodule.
 71. The method of claim 67, wherein forming the interconnectmember includes defining a void through which the electrical conductorextends, wherein the barrier comprises a material that fills at least aportion of the interconnect member void.
 72. The method of claim 67,wherein the barrier comprises a material that substantially encapsulatesat least a portion of the nonhermetic battery within the power sourcemodule housing.
 73. The method of claim 67, wherein the barriercomprises a getter within at least one of the power source modulehousing, the interconnect member, and the control module housing. 74.The method of claim 67, wherein the barrier comprises one of a gel, apolymer, or a solid electrolyte within the nonhermetic battery.
 75. Themethod of claim 65, further comprising forming a feedthrough, throughwhich the electrical conductor extends, as a part of the power sourcemodule housing.
 76. The method of claim 75, wherein forming the powersource module housing includes forming an interface area of the powersource module housing with the interconnect member that comprises athickness at least as thick as an outside cross-sectional area of thefeedthrough.
 77. The method of claim 65, further comprising forming afeedthrough, through which the electrical conductor extends, as a partof the control module housing.
 78. The method of claim 77, whereinforming the interconnect member includes forming an interface area ofthe interconnect member with the control module housing that comprises athickness at least as thick as an outside cross-sectional area of thefeedthrough.
 79. The method of claim 65, further comprising forming thepower source module housing and the interconnect member to comprisethicknesses less than an outside cross-sectional area of a feedthroughthrough which the electrical conductor extends.
 80. The method of claim65, wherein the components comprise control electronics.